Studies of m7G have shown that m7G modifications and its regulators METTL1, WDR4, and WBSCR22 are significantly upregulated in HCC and are associated with poor prognosis and chemotherapy resistance (Figure 3). This evidence concerns the gene METTL1 and hepatocellular carcinoma.